Triomune is a co-formulated medicine with a combination of three antiviral medicines. The tablets contain lamivudine 150mg, stavudine 30mg, and nevirapine 200mg anti-viral and are generally effective for the management of HIV infection. The tablets contain a generic version of nucleoside reverse transcriptase inhibitors, the non-nucleoside RTI and d4T. Cipla is the manufacturer of the medicine. These tablets work by preventing the HIV virus in the body to increase or multiply, thereby reducing the infection. It is also useful to increase leukocytes (white blood cells) count in the body.
The general use of the tablet is for HIV-AIDS, and Hepatitis B. The tablet is effective alone or also for any of these relatable issues. HIV is generally known as the virus that affects the immune system if the body. The virus can also spread up as it is a transmitting disease. The antiretroviral therapy of the tablet helps to control the risk and also helps to keep HIV from progressing to AIDS.
The dose and duration of Triomune tablets are prescribed by the doctor. The tablet is to be taken 1 hour before food on an empty stomach. The dose of the tablet is sometimes used with the combination of other medicines. Take the tablet as a whole without breaking or chewing it.
Avoid skipping or overdosing of the medicine to get proper benefits. Discuss allergic reactions or contradictions with the doctor before taking the tablets. The tablets help by interfering with the growth of the virus in the body. The benefits of use in pregnancy are also acceptable.
Avoid Triomune tablets if you are allergic to any of the active ingredients of the tablet or are having other allergies. Avoid dump and humid areas for the storage of the tablet. Do not take the medicine with alcohol. Adjust the tablet before intake and take the medicine till the prescription time.